Question 1

How many shares of ALPMY does SILVERCREST ASSET MANAGEMENT GROUP LLC own?

Accepted Answer

SILVERCREST ASSET MANAGEMENT GROUP LLC previously held 0 shares of ALPMY (Astellas Pharma Inc) before exiting the position in 2022-Q3.

Question 2

What is SILVERCREST ASSET MANAGEMENT GROUP LLC's ALPMY position worth?

Accepted Answer

SILVERCREST ASSET MANAGEMENT GROUP LLC's ALPMY position was last reported at $0 in 2022-Q3 before the exit.

Question 3

Is SILVERCREST ASSET MANAGEMENT GROUP LLC buying or selling ALPMY?

Accepted Answer

In 2022-Q3, SILVERCREST ASSET MANAGEMENT GROUP LLC exited their ALPMY position entirely (-100.0% change in shares).

Question 4

When did SILVERCREST ASSET MANAGEMENT GROUP LLC first buy ALPMY?

Accepted Answer

Based on available 13F filings, SILVERCREST ASSET MANAGEMENT GROUP LLC first reported a position in ALPMY in 2020-Q2. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$12.71	0
2022-Q2	Increased	112,833	+0.2%	$1.8M	0.0%	$14.84	26
2022-Q1	Decreased	112,575	-0.5%	$1.8M	0.0%	$14.86	0
2021-Q4	Increased	113,135	+2.4%	$1.8M	0.0%	$15.52	26
2021-Q3	Increased	110,460	+0.3%	$1.8M	0.0%	$15.76	26
2021-Q2	Decreased	110,145	-0.2%	$1.9M	0.0%	$16.58	0
2021-Q1	Increased	110,330	+18.3%	$1.7M	0.0%	$14.73	30
2020-Q4	Increased	93,260	+37.4%	$1.4M	0.0%	$14.73	33
2020-Q3	Decreased	67,895	-5.2%	$1M	0.0%	$14.22	0
2020-Q2	New	71,630	-	$1.2M	0.0%	$15.89	35

ALPMY10 quarters

ALPMY
10 quarters